ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 49 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,088 | -53.7% | 19,047 | -58.5% | 0.00% | – |
| Q2 2023 | $471,338 | +663.8% | 45,850 | +473.6% | 0.00% | – |
| Q1 2023 | $61,706 | +268.9% | 7,993 | +251.2% | 0.00% | – |
| Q4 2022 | $16,729 | +67.3% | 2,276 | +89.7% | 0.00% | – |
| Q2 2022 | $10,000 | -54.5% | 1,200 | -49.3% | 0.00% | – |
| Q1 2022 | $22,000 | -68.6% | 2,369 | -52.6% | 0.00% | – |
| Q4 2021 | $70,000 | +483.3% | 4,996 | +337.5% | 0.00% | – |
| Q3 2021 | $12,000 | +71.4% | 1,142 | +65.7% | 0.00% | – |
| Q1 2021 | $7,000 | -41.7% | 689 | -50.9% | 0.00% | – |
| Q3 2020 | $12,000 | +9.1% | 1,404 | +25.8% | 0.00% | – |
| Q2 2020 | $11,000 | +120.0% | 1,116 | -1.2% | 0.00% | – |
| Q2 2019 | $5,000 | +150.0% | 1,129 | +329.3% | 0.00% | – |
| Q1 2019 | $2,000 | -66.7% | 263 | -84.3% | 0.00% | – |
| Q4 2018 | $6,000 | -62.5% | 1,676 | -21.6% | 0.00% | – |
| Q2 2018 | $16,000 | +100.0% | 2,137 | +107.5% | 0.00% | – |
| Q1 2018 | $8,000 | – | 1,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
| BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
| Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
| Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
| DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |